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Aneurysmal iliac arteries do not portend future
iliac aneurysmal enlargement after endovascular
aneurysm repair for abdominal aortic aneurysm
Melissa L. Kirkwood, MD,a Alan Saunders, MS,b Benjamin M. Jackson, MD,a Grace J. Wang, MD,a
Ronald M. Fairman, MD,a and Edward Y. Woo, MD,a Philadelphia, Pa; and West Lafayette, Ind
Objectives: The purpose of this study was to examine the fate of aneurysmal iliac arteries managed during endovascular
aneurysm repair (EVAR) for abdominal aortic aneurysm (AAA).
Methods: We analyzed data from the Cook Zenith trial. Follow-up was at 1 month, 6 months, 12 months, and then
annually for 5 years. Patients were evaluated according to the largest iliac artery diameter: group A (>20 mm) and group
B (<20 mm). These groups were further subdivided based on iliac artery growth >5 mm during follow-up. The Fisher
exact test and 2 test were used.
Results:Of 736 patients treated, 671 had a follow-up examination (group A 274). In group A, 220 (80%) were treated
with flared limbs in the common iliac artery. Group A did not demonstrate increased iliac growth as compared to group
B. Furthermore, both groups had a similar percentage of patients that experienced iliac artery expansion of 32.1% and
31.5%, respectively. Extension to the external iliac artery did not affect growth (P  .4). No difference was noted in the
need for secondary interventions between groups. However, group A patients that did not experience growth were more
likely to develop a distal type I endoleak than group B patients who did not develop growth (P  .03). There was no
difference in serious adverse events (SAEs) between groups (P  .51). However, patients that developed iliac artery
growth in either group were less likely to have an SAE compared to patients who did not experience growth (P  .035).
There was no difference in the mean percent oversizing of the iliac limbs between groups A and B. However, the mean
percent oversizing in groups A and B that had iliac artery growth was significantly higher than in those that demonstrated
no growth (P < .01).
Conclusion: Aneurysmal iliac arteries managed by flared limbs or external iliac extensions at the time of EVAR for AAA
do not demonstrate future iliac growth, increased rate of secondary interventions, or SAEs compared to patients with
normal iliac arteries. This suggests that aneurysmal iliac arteries can be safely treated with appropriately sized limbs


















tConcomitant iliac artery aneurysms have been noted to
occur in 15% to 40% of patients who present with abdom-
inal aortic aneurysms (AAAs).1-5 Aneurysmal involvement
of the iliac arteries can pose a challenge during endovascular
repair of an AAA, requiring adjunctive procedures that can
lengthen the operative time and increase the injected con-
trast loads.2,3 In the era of endovascular aneurysm repair
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doi:10.1016/j.jvs.2010.08.062EVAR), aneurysmal common iliac arteries (CIAs) have
een managed largely by either placement of a flared iliac
imb appropriately sized to achieve an adequate distal seal
r extension of the graft into the external iliac with coil
mbolization of the internal iliac artery. Graft extension
ith coil embolization of the internal iliac artery can result
n buttock claudication, sexual dysfunction, and colonic
schemia.6-10 Distal fixation with a flared limb in the CIA
ould avoid these potential complications; however, it has
ot been established whether aneurysmal iliac arteries are
redisposed to additional growth.
Arterial dilation after EVAR could lead to failure of the
istal graft seal and subsequent aneurysmal sac expansion.
ata on the progression of iliac arteries after open AAA
epair have shown that the increase in CIA diameter may
epend on the vessel size at baseline, with aneurysmal CIAs
19 mm-25 mm in diameter) expanding at twice the
rowth rate of nonaneurysmal CIAs (12 mm in diame-
er).11 This study examines whether aneurysmal CIAs,
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February 2011270 Kirkwood et alEVAR, predispose patients to additional iliac artery growth,
increased secondary interventions, or serious adverse events
(SAEs).
METHODS
Data were analyzed from the Cook Zenith US multi-
center trial; device description, information about the study
design, procedural techniques, and follow-up have been
described previously.12,13 Briefly, the Zenith AAA endo-
vascular graft (Cook Incorporated, Bloomington, Ind) was
assessed for safety and effectiveness in a prospective, non-
randomized, case-controlled study. Between 2000 and
2003, 432 patients were enrolled in the pivotal study in
either the open surgery group (n 80) or the Zenith AAA
endovascular graft group (n  352). In a subsequent
“continued access” study, 387 patients were enrolled for
treatment with the Zenith graft using the same inclusion/
exclusion criteria as the pivotal study. Between the two
studies, 739 patients eligible for endovascular treatment
were enrolled. Device diameters were intended to be sized
10% to 15% larger than the measured arterial diameter.
Aneurysmal CIAs were treated with flared iliac limbs or by
extension of the endograft into the external iliac artery,
with coil embolization of the hypogastric artery. All aneu-
rysmal CIAs treated with a flared limb in the common
artery had a distal landing zone of 20 mm in diameter.
The range of CIA diameters at the largest segment that was
included in the study was 9.6 to 77.9 mm. Clinical evalua-
tion and computed tomography (CT) scans occurred post-
procedure and at 30 days, 6 months, 12 months, and then
annually for 5 years after graft placement. CT scans were
evaluated to determine maximum aneurysm diameter. The
reported diameters were based on outer-wall to outer-wall
measurements from core laboratory analysis of axial images.
The axial images analyzed were from flat films, and in the
presence of tortuosity, the diameter along the shortest axis
was measured.
The largest CIA diameter at baseline was identified for
each patient, and the patients were divided into two groups.
Group A was comprised of patients whose maximum CIA
diameters were 20 mm (range, 20-77.9 mm), and group
B was comprised of patients whose CIA diameters were
20mm (range, 9.6-19.9mm). These groups were further
subdivided based on the development of CIA growth (5
mm) during the follow-up period. Comparison between
patients in the two groups for discrete variables was per-
formed with the 2 or Fisher exact test, and continuous
data were analyzed using the t test. The data analyzed were
generated using SAS 9.1 software (SAS Institute Inc, Cary,
NC) and R2.10.1 software.
RESULTS
Of 736 patients treated, 671 (91.2%) had follow-up
data available. Of these 671 patients, 274 (40.8%) had
aneurysmal CIAs (group A) at baseline, whereas 397 pa-
tients had nonaneurysmal CIAs (group B) at the time of
EVAR. A total of 8.8% of the patient population (59 of
671) were treated with ancillary iliac leg distal attachment tites in the external iliac artery, and coil embolization of the
ypogastric artery. The mean follow-up period was similar
or groups A and B: 15.6 months and 14.8 months, respec-
ively (P  .22).
The majority of patients in both groups were men;
owever, there were significantly more women in group B
ompared to group A (11.3% vs 2.6%, P .01). The mean
ge was 72 years in both groups (P  .57). There was no
ignificant difference in comorbidities (Table I).
The mean maximum aortic aneurysm diameter was
imilar between groups: 58.1  8 mm (range, 43.3-86.7
m) for group A patients and 57.1  8 mm (range,
5.3-91.5 mm) for group B (P .19). The mean diameter
or CIAs in group Bwas 16.8 2.1mm and for aneurysmal
IAs (group A) was 51.4  7.4 mm. This measurement
efers to the largest diameter of the aneurysm and not
ecessarily the landing zone of the artery. There was no
ifference in procedure time (P  .11), total fluoroscopy
ime (P  .23), or amount of administered contrast (P 
43) between groups A and B. Coil embolization of the
ypogastric artery was performed at the time of EVAR in
.6% of patients in group A, and 0.8% of patients in group
. Group A patients did experience a significantly greater
mount of blood loss during the procedure (P .01; Table II).
Both groups A and B had a similar number of patients
ho developed CIA expansion during the follow-up pe-
iod: 32.1% (88 of 274) and 31.5% (125 of 397), respec-
ively (P  .87). As expected, group A patients were
ignificantly more likely to have graft coverage extended to
he external iliac artery (P  .01). Within group A, the
ajority of patients (80.2%; 220 of 274) were treated with
ared limbs. Further subgroup analysis examining patients
ithin group A who experienced growth compared to
able I. Clinical characteristics of patients with
neurysmal and nonaneurysmal common iliac arteries
actor
Group A Group B
P valuen  274 n  397
ge (years) 72  8 72  8 .57
emale gender 2.6% (7/274) 11.3% (45/397) .01
OPD 21.8% (60/274) 28.7% (114/397) .09
revious MI 32.8% (90/274) 34.8% (138/397) .34
iabetes 15.3% (42/274) 14.1% (56/397) .60
enal failure 1.5% (4/274) 1.0% (4/397) .92
OPD, Chronic obstructive pulmonary disease; MI, myocardial infarction.
able II. Procedural data
easure
Group A Group B P
valuen  274 n  397
rocedure time (hours) 3.8  1.2 3.7  1.1 .11
luoroscopy time
(minutes)
29.6  25.8 27.4  19.8 .23
ontrast used (cc) 159.6  73.1 155.1  72.9 .43
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iliac artery did not predispose the common iliac artery to
subsequent growth. In terms of absolute growth, when
comparing patients in group A who experienced CIA
growth to patients in group B who also demonstrated CIA
growth, there was no significant difference in the absolute
change in diameter in either the right or left CIA (Fig 1).
In total, 126 secondary interventions were performed
in 103 patients (15.4%; 103 of 671) during the follow-up
period. There was no difference in the number of secondary
interventions between groups A and B (19.7%; 54 of 274 vs
17.1%; 68 of 397; P  .23; Fig 2, a). Endoleak was the
major reason for repeat intervention, with type II endoleaks
being the most common (6.1%; 41 of 671). Although the
incidence of distal type I endoleak was higher in group A
(2.2%; 6 of 274) vs group B (0.5%; 2 of 397), this did not
reach significance (P  .07). Further subgroup analysis
demonstrated that the patients in group A who did not
experience growth were significantly more likely to have a
distal type I endoleak (2.1%; 4 of 186) than the respective
group B patients (0%; 0 of 272; P  .03). There was no
difference in endoleak rates between group A (2.3%) and
group B (1.6%) patients experiencing growth (P  .99).
The overall morbidity rate was 70% for all patients in
this study, with 1670 documented adverse events. Docu-
mented adverse events included: Q wave and non-Q wave
myocardial infarction, congestive heart failure, new onset
arrhythmia, paralysis, stroke, prolonged ventilation, need
for reintubation, pneumonia, renal failure requiring dialy-
Fig 1. a, Absolute change in right common iliac artery diameter.
b, Absolute change in left common iliac artery diameter.sis, bowel ischemia, distal embolization resulting in limb .schemia, need for transfusion, and local wound complica-
ions including dehiscence, infection, hematoma, and se-
oma formation. There was no significant difference in
orbidity between groups (P .5). Patients treated with a
ared limb in the CIA rather than endograft extension into
he external iliac artery did not demonstrate an increased
isk of morbidity.
Thirty-day survival was 100% for group A and 99.1% for
roup B. Likewise, there was no difference in aneurysm-
elated mortality between groups (Fig 2, b). SAE, defined
s aneurysm rupture, conversion to open repair, and death,
ere also similar between groups A and B (P .99). There
as a total of 102 deaths in the study. There were no early
onversions to open repair in either group, nor was there a
ifference in the number of conversions between groups.
ndications for conversion included: aneurysmal degenera-
ion of the visceral segment, aortic rupture, persistent type
endoleak, and graft infection. Upon subgroup analysis,
atients in groups A and B who did not experience CIA
rowth demonstrated a higher frequency of SAE (18.8%;
4 of 458) compared to patients who did experience
rowth (9.9%; 21 of 213; P  .035). The distal extent of
evice fixation, whether in the common or external iliac
rtery, did not significantly impact adverse event rates (P
ig 2. a, Kaplan-Meier estimates of freedom from secondary
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was supposed to be oversized by 10% to 15% based on
measurements made by CT scan or conventional angiog-
raphy at the intended attachment site. There was no
statistically significant difference between average mean
percent graft oversizing between groups A and B. How-
ever, further subgroup analysis demonstrated that within
each respective group, patients who experienced CIA
growth had larger endograft oversizing compared to
patients who did not experience growth (mean percent-
age graft oversizing group A: with growth 12.4% vs no
growth 2.1% P  .01; group B: with growth 14.9% vs no
growth 0.6%; P  .01).
DISCUSSION
Treatment of aneurysmal CIAs during EVAR is typi-
cally performed with flared limbs or extension into the
external iliac arteries. Currently, the maximum diameter of
the commercially available endograft limbs for EVAR is 24
mm; therefore, patients with CIAs 22 mm in diameter
often require extension of the endograft into the external
iliac artery.14 Various series have estimated that external
iliac extension is still necessary in approximately 15% to 30%
of patients with aneurysmal common iliacs despite the
availability of flared limbs.7,9,15-17 In this series, 80% of
patients with aneurysmal CIAs (group A) were treated with
flared limbs in the CIA.
The risk of continued enlargement is a major concern
when treating aneurysmal iliac arteries, especially when
treatment involves the use of flared limbs. Iliac artery
enlargementmay cause failure of the distal graft seal leading
to aortic or iliac artery aneurysmal growth and potential
rupture.18 As demonstrated in this study, patients with
aneurysmal iliac arteries had a higher tendency for type Ib
endoleaks.
In general, the determination of whether an iliac artery
is aneurysmal depends somewhat on the baseline vessel size.
That is, a 19 mm iliac in a petite patient is not the same as
a 19 mm iliac in a large patient. Traditional recommenda-
tions for intervention on an isolated common iliac aneu-
rysm are usually 3 cm. However, if a concomitant AAA is
being treated, then we usually treat all enlarged iliacs simul-
taneously. Ballota et al11 demonstrated that aneurysmal
CIAs (19-25 mm in diameter) had twice the growth rate
compared to nonaneurysmal CIAs (12 mm in diameter)
after elective open infrarenal abdominal aortic aneurysm
repair. Others, however, have shown no significant diame-
ter increase in aneurysmal iliac arteries 4 years after aortic
tube graft repair.19 Ultimately, the question is whether
treatment of iliac artery aneurysms with current endovas-
cular techniques is feasible and durable. The current study
demonstrates that patients with aneurysmal CIAs at base-
line are not at increased risk for subsequent growth after
EVAR.Moreover, treatment with flared limbs placed in the
CIA do not predispose to future growth as compared to
extension into the external iliac artery. flPrevious reports have suggested that the presence of
neurysmal CIAs at the time of EVAR increases the rate of
ndoleaks and secondary interventions.20 Hobo et al,21
ompared outcomes after EVAR in patients with and with-
ut concomitant CIA aneurysms. Patients with aneurysmal
IAs at baseline had a significantly higher cumulative inci-
ence of distal type I endoleaks, iliac limb occlusion, sec-
ndary interventions, and aneurysm rupture compared
ith patients with nonaneurysmal CIAs. In contrast, the
urrent study demonstrated no difference in the need for
econdary interventions between groups. The finding that
atients with aneurysmal CIA at baseline who did not
xperience growth were significantly more likely to develop
distal type I endoleak than those patients with nonaneu-
ysmal CIA who also did not grow suggests that difficulty
ay be encountered in maintaining an appropriate seal in
neurysmal CIA over time. This may be due to the landing
ones in the aneurysmal arteries being shorter in length and
arger in diameter allowing for less durability over time in
ontrast to the nonaneurysmal arteries which may be more
niform in the landing zone. This then may predispose to
n endoleak over time. However, in those patients that had
rterial growth over time, there was no difference in en-
oleak rates between groups A and B. This occurred be-
ause both groups developed endoleaks due to vessel en-
argement. Although, the aneurysmal group had more
ndoleaks, this did not reach statistical significance given
he endoleaks that also formed in group B. With increased
ower, this might reach statistical significance.
Although there was no significant difference inmorbid-
ty or SAEs between groups A and B, patients who did not
xperience CIA growth in both groups demonstrated a
igher frequency of SAEs compared with patients who did
xperience growth. It is unclear why patients with future
IA growth would have a lower incidence of SAEs during
VAR. A possible explanation might be that patients who
xperienced growthmay have hadmore careful surveillance
nd/or earlier intervention for events that might lead to an
AE, such as an endoleak. Ultimately, there may be no
elation between the events. Flared limbs or exclusion of
he aneurysmal common iliac with external iliac fixation did
ot affect the rate of aneurysm rupture, conversion to open
epair, or mortality.
In the current study, patients who developed CIA
rowth, regardless of baseline CIA diameter, had signifi-
antly oversized grafts compared to patients who did not
xperience growth. This finding suggests that significantly
versizing the endograft may lead to future growth. This
ay be due to increased radial force on the artery ultimately
esulting in expansion. Thus, excessive oversizing remains
n important consideration, as doing so may lead to future
roblems.
In summary, current techniques for endovascular man-
gement of concurrent CIA aneurysms does not predispose
o future growth of these aneurysmal vessels. Furthermore,
ates of secondary interventions, morbidity, or adverse
vents are also not affected. Importantly, utilization of
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choice, however, is important as too much oversizing may
contribute to future growth. Ultimately, treatment of con-
current common iliac artery aneurysms can result in excel-
lent and durable results.
The authors acknowledge Christina Allen and Scott
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